NO992063L - Benzoksazolderivat med affinitet til bindingssteder pÕ aminosyrereseptorer - Google Patents
Benzoksazolderivat med affinitet til bindingssteder pÕ aminosyrereseptorerInfo
- Publication number
- NO992063L NO992063L NO992063A NO992063A NO992063L NO 992063 L NO992063 L NO 992063L NO 992063 A NO992063 A NO 992063A NO 992063 A NO992063 A NO 992063A NO 992063 L NO992063 L NO 992063L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- affinity
- binding sites
- acid receptors
- benzoxazole derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19643790A DE19643790A1 (de) | 1996-10-30 | 1996-10-30 | Benzoxazol-Derivat |
| PCT/EP1997/005590 WO1998018793A1 (de) | 1996-10-30 | 1997-10-10 | Benzoxazolderivat mit affinität zu bindungsstellen von aminosäurerezeptoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992063D0 NO992063D0 (no) | 1999-04-29 |
| NO992063L true NO992063L (no) | 1999-04-29 |
Family
ID=7809592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992063A NO992063L (no) | 1996-10-30 | 1999-04-29 | Benzoksazolderivat med affinitet til bindingssteder pÕ aminosyrereseptorer |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0938485A1 (ko) |
| JP (1) | JP2001502713A (ko) |
| KR (1) | KR20000052876A (ko) |
| CN (1) | CN1235604A (ko) |
| AR (1) | AR008512A1 (ko) |
| AU (1) | AU4946597A (ko) |
| BR (1) | BR9712577A (ko) |
| CA (1) | CA2270359A1 (ko) |
| CZ (1) | CZ147999A3 (ko) |
| DE (1) | DE19643790A1 (ko) |
| HU (1) | HUP9904547A3 (ko) |
| NO (1) | NO992063L (ko) |
| PL (1) | PL332771A1 (ko) |
| SK (1) | SK53699A3 (ko) |
| WO (1) | WO1998018793A1 (ko) |
| ZA (1) | ZA979725B (ko) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9725541D0 (en) * | 1997-12-02 | 1998-02-04 | Pharmacia & Upjohn Spa | Amino-benzothiazole derivatives |
| DE19812331A1 (de) * | 1998-03-20 | 1999-09-23 | Merck Patent Gmbh | Piperidinderivate |
| PE20000728A1 (es) | 1998-06-26 | 2000-08-21 | Cocensys Inc | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda |
| US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| EP1674087A1 (en) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
| DE10120159A1 (de) * | 2001-04-25 | 2002-10-31 | Merck Patent Gmbh | NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen |
| MXPA04000737A (es) | 2001-07-24 | 2004-07-08 | Richter Gedeon Vegyeszet | Derivados de piperidina como antagonistas receptores de nmda. |
| DE102007047737A1 (de) | 2007-10-05 | 2009-04-30 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| DE102009049211A1 (de) | 2009-10-13 | 2011-04-28 | Merck Patent Gmbh | Sulfoxide |
| SG10201800159QA (en) | 2011-11-22 | 2018-02-27 | Univ California | Cysteamine and/or cystamine for treating ischemic injury |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2128629T3 (es) * | 1994-10-31 | 1999-05-16 | Merck Patent Gmbh | Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos. |
-
1996
- 1996-10-30 DE DE19643790A patent/DE19643790A1/de not_active Withdrawn
-
1997
- 1997-10-10 HU HU9904547A patent/HUP9904547A3/hu unknown
- 1997-10-10 WO PCT/EP1997/005590 patent/WO1998018793A1/de not_active Application Discontinuation
- 1997-10-10 BR BR9712577-6A patent/BR9712577A/pt not_active Application Discontinuation
- 1997-10-10 AU AU49465/97A patent/AU4946597A/en not_active Abandoned
- 1997-10-10 PL PL97332771A patent/PL332771A1/xx unknown
- 1997-10-10 SK SK536-99A patent/SK53699A3/sk unknown
- 1997-10-10 KR KR1019990703727A patent/KR20000052876A/ko not_active Application Discontinuation
- 1997-10-10 CA CA002270359A patent/CA2270359A1/en not_active Abandoned
- 1997-10-10 CN CN97199279A patent/CN1235604A/zh active Pending
- 1997-10-10 JP JP10519971A patent/JP2001502713A/ja active Pending
- 1997-10-10 CZ CZ991479A patent/CZ147999A3/cs unknown
- 1997-10-10 EP EP97912162A patent/EP0938485A1/de not_active Withdrawn
- 1997-10-29 ZA ZA9709725A patent/ZA979725B/xx unknown
- 1997-10-29 AR ARP970105012A patent/AR008512A1/es unknown
-
1999
- 1999-04-29 NO NO992063A patent/NO992063L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR008512A1 (es) | 2000-01-19 |
| NO992063D0 (no) | 1999-04-29 |
| JP2001502713A (ja) | 2001-02-27 |
| HUP9904547A2 (hu) | 2000-12-28 |
| DE19643790A1 (de) | 1998-05-07 |
| BR9712577A (pt) | 1999-10-19 |
| CN1235604A (zh) | 1999-11-17 |
| KR20000052876A (ko) | 2000-08-25 |
| AU4946597A (en) | 1998-05-22 |
| ZA979725B (en) | 1998-05-22 |
| CZ147999A3 (cs) | 1999-08-11 |
| HUP9904547A3 (en) | 2001-01-29 |
| PL332771A1 (en) | 1999-10-11 |
| WO1998018793A1 (de) | 1998-05-07 |
| SK53699A3 (en) | 2000-03-13 |
| CA2270359A1 (en) | 1998-05-07 |
| EP0938485A1 (de) | 1999-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO992063L (no) | Benzoksazolderivat med affinitet til bindingssteder pÕ aminosyrereseptorer | |
| NO20004668L (no) | 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister | |
| ATE501133T1 (de) | Substituierte indole und deren verwendung als 5ht-wiederaufnahme inhibitoren und als 5ht liganden | |
| CN100335479C (zh) | 糖元合成酶激酶3的双环抑制剂 | |
| CN1272328C (zh) | 糖元合成酶激酶3的基于吡嗪的抑制剂 | |
| Allnutt et al. | Physiological and pathological roles of Cdk5: potential directions for therapeutic targeting in neurodegenerative disease | |
| PH12018500940A1 (en) | N-[2-(1 -benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1 -carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases | |
| WO2001029012A3 (en) | Benzodiazepine derivatives as metabotropic glutamate receptor antagonists | |
| NZ765495A (en) | 1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer’s disease | |
| NO20013444D0 (no) | Triazolforbindelser med dopamin-D3-reseptor-affinet | |
| MXPA05009524A (es) | Derivados de imidazol-4-il-etinil-piridina. | |
| WO2008034016A3 (en) | Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins | |
| DE602006010540D1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor | |
| AU4007900A (en) | Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands | |
| Caudron et al. | Mutation of Ser172 in yeast β tubulin induces defects in microtubule dynamics and cell division | |
| WO2006138355A3 (en) | Effect of bri proteins on abeta production | |
| ATE393781T1 (de) | Somatostatin analoge, deren radiomarkierte derivate und deren verwendung | |
| Fagerholm et al. | Autoradiographic characterization of α2C‐adrenoceptors in the human striatum | |
| WO2004093790A3 (en) | Yeast ectopically expressing abnormally processed proteins and uses therefor | |
| ATE264323T1 (de) | Heterocyclische verbindungen und ihre verwendung als angiotensin ii antagonisten | |
| ATE529114T1 (de) | Tetrahydrobenzazepine und ihre verwendung in der modulation des dopamin-d3-rezeptors | |
| AU2013304212B2 (en) | Arylethynyl pyrimidines | |
| JP2023502605A (ja) | タウタンパク質凝集物を分解する化合物及びその使用 | |
| DE602006007682D1 (de) | 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen | |
| PL433141A1 (pl) | Zastosowanie 3-{[4-(5-metoksy-1H-indol-3-ylo)-1,2,3,6-tetrahydropirydyn-1-ylo]metylo}-1,2-dihydrochinolin-2-onu (D2AAK1) oraz sposób wytwarzania i zastosowanie jego nowych pochodnych do leczenia chorób neurodegeneracyjnych |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |